Preclinical evaluation of illudins as anticancer agents.
Data up to Jan 2025
Total Citations Per Year
Abstract
References (14)
Establishment and identification of small cell lung cancer cell lines having classic and variant features
1986 • 896 citations
Altered surface membrane glycoproteins in Vinca alkaloid-resistant human leukemic lymphoblasts.
1979 • 478 citations
Application of a human tumor colony-forming assay to new drug screening.
1985 • 217 citations
Antibiotic Substances from Basidiomycetes
1950 • 102 citations
Reversal of Vinca alkaloid resistance but not multiple drug resistance in human leukemic cells by verapamil.
1986 • 96 citations
Preclinical drug development: rationale and methods.
1981 • 92 citations
The Structures of the Basidiomycete Metabolites Illudin S and Illudin M
1963 • 91 citations
Effects of anti‐transferrin receptor antibodies on growth of normal and malignant myeloid cells
1983 • 82 citations
The National Cancer Institute antitumor drug discovery program, current and future perspectives: a commentary.
1983 • 51 citations
Preclinical studies on the use of selective antibody-ricin conjugates in autologous bone marrow transplantation
1985 • 36 citations
KB Cell Culture. I. Role in Discovery of Antitumor Agents From Higher Plants
1982 • 28 citations
Use of nude mouse xenografts as preclinical drug screens: Further studies onin vitro growth of xenograft tumor colony-forming cells
1986 • 18 citations
In vitro drug testing using hemopoietic cells: Goals and limitations
1985 • 10 citations
Csf‐responsive bone marrow cells in liquid culture: Characterization and screening applications
1986 • 6 citations